Skip to content

Delving Into Borderline Personality Disorder Clinical Trial Experiences

Uncovering Clinical Trial Engagement Among Individuals With Borderline Personality Disorder

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05989529
Enrollment
500
Registered
2023-08-14
Start date
2024-09-30
Completion date
2026-09-30
Last updated
2023-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Borderline Personality Disorder

Keywords

borderline personality disorder

Brief summary

Taking part in medical study usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This study will admit a wide range of data on the clinical research experience of borderline personality disorder patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future borderline personality disorder patients.

Interventions

None listed

Sponsors

Power Life Sciences Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aged ≥ 18 years old * Clinical diagnosis of Borderline Personality Disorder * Able to comprehend the investigational nature of the protocol and provide informed consent

Exclusion criteria

* No diagnosis of Borderline Personality Disorder confirmed * Inability to perform regular electronic reporting * Patient does not understand, sign, and return consent form

Design outcomes

Primary

MeasureTime frame
Number of patients who decide to enroll in a borderline personality disorder clinical research3 months
Rate of patients who remain in borderline personality disorder clinical research to trial completion12 months

Countries

United States

Contacts

Primary ContactMichael B Gill
bask@withpower.com415-900-4227

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026